NCCN 1st Annual Forum: Innovative Diagnostics & Therapeutics in Cancer Care™

NCCN 3rd Annual Congress: Hematologic Malignancies™

* Industry registrants will automatically be registered for both programs.

If you register and then cannot attend, a substitute attendee may be sent in your place. All Industry Registrants will be charged a $50 administration fee for each substitution. Registration and administrative fees for Industry are not refundable.

This Forum is supported by educational grants from AstraZeneca and Abraxis BioScience, Bristol-Myers Squibb and ImClone Systems Incorporated, Genentech BioOncology, Merck Oncology, sanofi-aventis U.S., and Takeda.

Tags: Events // Add Comment »

August 19, 2008 Ross Ade, Purdue Campus

Join us for this landmark educational event offering a combined program for physicians, scientists, biomedical engineers, and advocates to interact and problem-solve about issues in oncology.

Objective: To connect basic scientists at Purdue and the Hoosier Oncology Group network with the intent to develop collaborations and avenues to share intellectual and physical resources such as biospecimens.

To download the educational symposium agenda go to: http://www.hoosieroncologygroup.com/resources/HOG_EdSympFlyer2008.pdf

For registration and program information go to:  www.hoosieroncologygroup.com/golf.aspx

Tags: Events // Add Comment »

Washington, D.C. – May 21, 2008 – The Coalition for Genetic Fairness (http://www.geneticfairness.org/) commends President George W. Bush for signing into law today the first civil rights legislation of the new millennium, the Genetic Information Nondiscrimination Act (GINA). GINA is the first and only federal legislation that will provide protections against discrimination based on an individual’s genetic information in health insurance coverage and employment settings.
(more…)

Tags: Legislative news, News from Research Advocacy Network // Add Comment »